Company name
2022Founder
Wesley Wierson founded and leads LEAH Labs, developing gene-edited cell therapies for cancer in pets. He invented the GeneWeld gene-editing platform during doctoral research at Iowa State and applies genome engineering to translational medicine and biotech company building.
Founder & CEO
Director & Venture Engineer
PhD, Molecular, Cellular and Developmental Biology
BS, Microbiology